KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other financing activities: 2012-2016

Historic Other financing activities for Novavax (NVAX) over the last 5 years, with Dec 2016 value amounting to $10.0 million.

  • Novavax's Other financing activities was N/A to $10.0 million in Q1 2016 from the same period last year, while for Mar 2016 it was $9.8 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2016, which is 8009.52% up from last year.
  • Per Novavax's latest filing, its Other financing activities stood at $10.0 million for FY2016, which was up 8,009.52% from -$126,000 recorded in FY2015.
  • Novavax's Other financing activities' 5-year high stood at $10.0 million during FY2016, with a 5-year trough of -$756,000 in FY2012.
  • In the last 3 years, Novavax's Other financing activities had a median value of -$2,000 in 2014 and averaged $3.3 million.
  • Its Other financing activities has fluctuated over the past 5 years, first plummeted by 6,200.00% in 2015, then surged by 8,009.52% in 2016.
  • Novavax's Other financing activities (Yearly) stood at -$756,000 in 2012, then surged by 99.87% to -$1,000 in 2013, then tumbled by 100.00% to -$2,000 in 2014, then slumped by 6,200.00% to -$126,000 in 2015, then surged by 8,009.52% to $10.0 million in 2016.